The invention relates to a medicament containing (S)-2-N-propylamino-5-hydroxytetralin,the salts or prodrugs thereof. As a D3 agonist, (S)-2-N-propylamino-5-hydroxytetralinis suitable particularly for the treatment of dopa-sensitive movementdisorders.